Del Amo J - Search Results

1

Determining the likely place of HIV acquisition for migrants in Europe combining subject-specific information and biomarkers data.

Pantazis N, Thomadakis C, Del Amo J, Alvarez-Del Arco D, Burns FM, Fakoya I, Touloumi G. Pantazis N, et al. Among authors: del amo j. Stat Methods Med Res. 2019 Jul;28(7):1979-1997. doi: 10.1177/0962280217746437. Epub 2017 Dec 12. Stat Methods Med Res. 2019. PMID: 29233073

2

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K; CASCADE Collaboration. Bhaskaran K, et al. JAMA. 2008 Jul 2;300(1):51-9. doi: 10.1001/jama.300.1.51. JAMA. 2008. PMID: 18594040

3

Response to combination antiretroviral therapy: variation by age.

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA, Smith CJ, d'Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, et al. AIDS. 2008 Jul 31;22(12):1463-73. doi: 10.1097/QAD.0b013e3282f88d02. AIDS. 2008. PMID: 18614870

4

Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.

Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernández-Aguado I, Meyer L, Porter K, del Amo J; CASCADE Collaboration. Jarrin I, et al. Among authors: del amo j. Am J Epidemiol. 2008 Sep 1;168(5):532-40. doi: 10.1093/aje/kwn179. Epub 2008 Jul 28. Am J Epidemiol. 2008. PMID: 18663213

5

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.

Touloumi G, Pantazis N, Stirnadel HA, Walker AS, Boufassa F, Vanhems P, Porter K; CASCADE Collaboration. Touloumi G, et al. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):492-8. doi: 10.1097/QAI.0b013e318186ead2. J Acquir Immune Defic Syndr. 2008. PMID: 18989233

6

The effect of antiretroviral treatment of different durations in primary HIV infection.

Pantazis N, Touloumi G, Vanhems P, Gill J, Bucher HC, Porter K; CASCADE Collaboration. Pantazis N, et al. AIDS. 2008 Nov 30;22(18):2441-50. doi: 10.1097/QAD.0b013e328319ea4e. AIDS. 2008. PMID: 19005267

7

Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions.

Brown AE, Gifford RJ, Clewley JP, Kucherer C, Masquelier B, Porter K, Balotta C, Back NK, Jorgensen LB, de Mendoza C, Bhaskaran K, Gill ON, Johnson AM, Pillay D; Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration. Brown AE, et al. J Infect Dis. 2009 Feb 1;199(3):427-31. doi: 10.1086/596049. J Infect Dis. 2009. PMID: 19133810

8

Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, et al. Antivir Ther. 2009;14(8):1065-74. doi: 10.3851/IMP1462. Antivir Ther. 2009. PMID: 20032536 Free PMC article.

9

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC; CASCADE Collaboration Members. Wolbers M, et al. PLoS Med. 2010 Feb 23;7(2):e1000239. doi: 10.1371/journal.pmed.1000239. PLoS Med. 2010. PMID: 20186270 Free PMC article.

10

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters